Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023

BUY
$90.94 - $199.54 $104,581 - $229,471
1,150 Added 100.0%
2,300 $209,000
Q4 2022

Feb 01, 2023

SELL
$102.55 - $135.33 $10,767 - $14,209
-105 Reduced 8.37%
1,150 $155,000
Q3 2022

Oct 21, 2022

BUY
$95.28 - $116.93 $10,004 - $12,277
105 Added 9.13%
1,255 $125,000
Q1 2022

Apr 25, 2022

BUY
$93.1 - $112.54 $93 - $112
1 Added 0.09%
1,150 $128,000
Q4 2021

Jan 25, 2022

BUY
$95.88 - $117.08 $57,911 - $70,716
604 Added 110.83%
1,149 $129,000
Q1 2020

May 06, 2020

BUY
$49.46 - $64.78 $6,182 - $8,097
125 Added 29.76%
545 $32,000
Q2 2018

Aug 09, 2018

SELL
$44.29 - $50.42 $4,429 - $5,042
-100 Reduced 19.23%
420 $19,000
Q1 2018

May 11, 2018

BUY
$48.49 - $58.14 $25,214 - $30,232
520 New
520 $25,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Private Ocean, LLC Portfolio

Follow Private Ocean, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Ocean, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Ocean, LLC with notifications on news.